- Investment firm KKR is acquiring Integer Holdings Corporation for approximately $4.3 billion in cash.
- The deal values each share at $127.00, leading analyst firm Oppenheimer to downgrade the stock to 'Perform'.
- A shareholder rights law firm is investigating the fairness of the $127.00 per share acquisition price.
Integer Holdings Corporation (NYSE: ITGR) is a company that provides outsourced services for making medical devices. It operates in a market where it helps larger medical firms develop and manufacture their products. This medical device company is now the subject of a major acquisition by the investment firm KKR.
As highlighted by the WSJ, KKR agrees to buy Integer Holdings Corporation for approximately $4.3 billion in cash. This acquisition deal values each share of the company at $127.00. An acquisition sets a fixed price for a company's stock, which influences how analysts view its future performance.
Following this news, analyst firm Oppenheimer downgrades its rating on Integer Holdings Corporation from Outperform to Perform on August 3, 2026. This change suggests that analysts believe the stock will now perform in line with the market, as its price is unlikely to rise much beyond the acquisition price.
The stock price for Integer Holdings Corporation is $124.45 at the time of the rating change, which is close to the sale price. The stock shows a daily gain of 2.67%, or $3.24, and reaches a new 52-week high of $125.54. The company's market capitalization, or total value, is about $4.23 billion.
Meanwhile, investor rights law firm Halper Sadeh LLC launches an investigation into the sale. The firm is examining whether the $127.00 per share price is fair for Integer Holdings Corporation shareholders. This questions if the company's board of directors secured the best possible value in the deal with KKR.